Bivin & Associates’s Progyny PGNY Stock Holding History

Bivin & Associates’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10	Closed	-$1K	–	404
2021 Q4	$1K	Buy	+10	New	+$560	﹤0.01%	354

Other funds holding PGNY

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bivin & Associates's PGNY Position: Q1 2022 in Review

Bivin & Associates sold out of Progyny (PGNY) in Q1 2022, closing a stake of 10 shares — an estimated $1K sold.

Bivin & Associates first reported a position in PGNY in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 255 funds tracked by Wall St. Rank hold PGNY as of Q1 2022.

Bivin & Associates reported no remaining Progyny position as of Q1 2022 after selling out during the quarter.
Bivin & Associates sold 10 Progyny shares in Q1 2022, an estimated $1K.
Bivin & Associates first reported a position in Progyny in Q4 2021 and held it in 1 quarter.
Bivin & Associates's Progyny position peaked at $1K in Q4 2021.
255 funds tracked by Wall St. Rank held Progyny as of Q1 2022.

Based on Bivin & Associates's 13F filing for Q1 2022, filed 6 May 2022.